BioPharma Dive November 8, 2024
Amy Baxter

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate if given a role in the incoming Trump administration.

With the U.S. presidential election decided, one name is suddenly circulating in healthcare: Robert F. Kennedy Jr.

President-elect Donald Trump has promised Kennedy a large role in his new administration, signaling he could be handed influence guiding some of the nation’s health policies. And Kennedy, who does not have medical or public health degrees, has made it clear he has big ideas for change.

This week, Kennedy outlined three goals directed to him from Trump: “clean up corruption,” return health agencies to evidence-based science and “make america healthy again.” He didn’t present evidence of corruption, nor acknowledge...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
MedPAC estimates $84B in Medicare Advantage overpayments in 2025: 10 notes
MedPAC Report Calls for Increases in Doc Pay for Medicare Services
OpenAI calls for US to centralize AI regulation
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
Telehealth regulations in Washington, D.C.: The most pressing need in policy

Share This Article